Non-squamous Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-squamous Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC [Phase 2]
A Phase 2 clinical trial is evaluating visugromab in combination with immunochemotherapy as first-line treatment for metastatic non-squamous…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC [Phase 1]
Phase 1 study evaluating the safety and feasibility of combining pirfenidone with standard first-line chemotherapy in advanced non-small cel…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLC [Phase 3]
Phase 3 randomized trial of pemetrexed with platinum chemotherapy with or without cosibelimab in first-line metastatic non-squamous non-smal…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC [Phase 2]
Phase 2 trial of Tusamitamab Ravtansine (SAR408701) with pembrolizumab, with or without platinum-based chemotherapy with/without pemetrexed,…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating platinum-based chemotherapy with or without INCMGA00012 (retifanlimab) in metastatic non-small cell lung cancer has…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial updating results for platinum-based chemotherapy with or without INCMGA00012 (an anti-PD-1 antibody) in metastatic non-small c…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Safety of Effivia®, a Bevacizumab Biosimilar
Completed safety data for Effivia, a bevacizumab biosimilar, from a clinical trial sponsored by Laboratorios Liomont. The study evaluated it…
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure [Phase 3]
A Phase 3 trial evaluating sintilimab with IBI305 plus pemetrexed and cisplatin for EGFR-mutant, locally advanced or metastatic non-squamous…
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy [Phase 2]
Phase 2 trial evaluating lazertinib as consolidation therapy after chemoradiation in locally advanced, unresectable EGFR-mutant non-small ce…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer [Phase 3]
A phase 3 clinical trial comparing bevacizumab plus erlotinib versus erlotinib alone as first-line treatment for EGFR-mutated advanced non-s…
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing BAT1706 to EU Avastin in advanced non-squamous non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-29Clinical Trial Update: Camrelizumab Plus Apatinib for Advanced Non-Squamous NSCLC Previously Treated With First-Line Immunotherapy [Phase 2]
Phase 2 trial evaluating camrelizumab in combination with apatinib for advanced non-squamous non-small cell lung cancer previously treated w…
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC). [Phase 2]
Phase 2 trial evaluating R1507 plus Erlotinib in non-squamous non-small cell lung cancer; trial terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-19Clinical Trial Update: A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating anlotinib hydrochloride in combination with chemotherapy versus placebo with chemotherapy as first-line treatment f…
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC [NA]
Clinical trial update reporting dose escalation of bevacizumab with ambulatory blood pressure monitoring in patients with advanced non-squam…
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial of atezolizumab with carboplatin and nab-paclitaxel vs carboplatin and nab-paclitaxel in stage IV non-squamous non-small cell …
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial update evaluating SCT510 for non-small cell lung cancer (non-squamous) is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating QL1101 and Avastin in combination with paclitaxel and carboplatin as first-line therapy for non-squamous non-smal…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE) [Phase 2]
Phase 2 trial evaluating MEGF0444A in combination with carboplatin, paclitaxel, and bevacizumab in patients with advanced or recurrent non-s…